Canine Biologics Appoints David Haworth to Board of Directors
DENVER, CO, September 30, 2021 / 24-7PressRelease / – Canine Biologics today announced the appointment of David Haworth to its Board of Directors.
Dr. Haworth, DVM, Ph.D., brings over 20 years of experience in the animal health industry. Haworth is the president and co-founder of Vidium Animal Health. Previously, he was President of PetSmart Charities in the United States and Canada, and CEO of Morris Animal Foundation. Haworth also served as Director of Global Alliances and Director of Research and Development at Pfizer Animal Health (now Zoetis). He holds a DMV and PhD from Colorado State University and did a postdoctoral fellowship at the Flint Animal Cancer Center at Colorado State University. Haworth truly understands the impact this disease can have as his Labrador Retriever, Bridger, is a cancer survivor.
“We are delighted to welcome David to our Board of Directors at this important stage in the evolution of Canine Biologics,” said Jeff Sutherland, President and CEO of Canine Biologics. “As a highly respected and seasoned executive and veterinarian with valuable industry experience, we look forward to David’s engagement and expert assistance to guide our goals of bringing revolutionary nutrition to market against cancer and related products for veterinarians, veterinary oncologists and pet owners. “
“I am delighted to join the Canine Biologics Board of Directors,” said Dr. Haworth. “I look forward to working alongside my fellow board members and company leadership to advance truly innovative products that benefit cancer-fighting pets.
About organic canine products
Canine Biologics is a nutrition company focused on developing new and innovative products to support pets in their fight against cancer and certain other critical care needs. Canine Biologics’ flagship product, its integrated nutrition system, is available to pet parents and veterinarians across the United States and is expected to be available in Canada and other international markets soon. Additional products are under development and will be rolled out over the next 12-18 months. Additional information on Canine Biologics can be obtained at http://www.caninebiologics.com.
Press release service and press release distribution provided by http://www.24-7pressrelease.com